Digital Tech for good: AI agents critical to improving NHS services How NHS Trusts are harnessing the latest AI solutions to optimise the experience for their employees and care on behalf of patients.
Digital Unicorns, AI, and the future of health: Highlights from HLTH... Deep Dive editor Eloise McLennan debriefs on the key themes, hot topics, and hallway conversations that shaped the HLTH event in Amsterdam.
Digital Why security-first design is the fix to stalling AI pilot to... For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.
Digital Asking the right questions around AI, with Brian Alexander, ... At BIO 2025, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve.
Digital Beyond AI hype: How dynamic study forecasting is helping pha... The industry must move beyond hype and address the real-world applications of AI for accurate enrolment forecasting.
Digital Sponsored Axtria Ignite 2025: Jaswinder Chadha on driving life science... At Axtria Ignite 2025, web editor Nicole Raleigh spoke with the company’s co-founder, president, and CEO Jaswinder Chadha.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.